Dr John Horton
Dr John Horton is a medical practitioner with over 35 years of experience in tropical medicine, including malaria, helminths, leishmaniasis, diarrhoeal diseases, and TB. He was the moving force behind the tropical disease initiatives at GlaxoSmithKline (GSK) and helped establish the Medicines for Malaria Venture and the Global Alliance for TB Drug Development. As an industry member of the WHO/IFPMA working party, he was instrumental in the elevation of ‘Neglected Diseases’ into the public arena, and of GSK in Public Private Partnerships with the WHO to develop drugs for tropical diseases and affordable access to modern pharmaceutical products in public health.
Dr Horton has been an Honorary RSTMH Fellow since 2003 and was Vice President during the Society’s Centenary celebrations (2005-2007). He also served as a Trustee on the RSTMH Board between 2013 -2016. Although retired, Dr Horton continues to support public health programmes and new drug development as a consultant to the WHO and to drug development consortia.